This statistic depicts how some pharmacy benefit managements (PBMs) and specialty pharmacy executives define specialty drugs as of 2011. Some 69 percent considered biotechnically engineered drugs as specialty drugs. Generally, specialty drugs are characterized by having high cost per unit; treating complex chronic or life-threatening conditions; requiring special storage, handling or administration; and require significant degree of patient education, monitoring, and management.
Share of indications which define a specialty drug as of 2011*
Characteristic
Share of responses
High-unit cost drugs
61%
Drugs requiring special handling or storage
69%
Drugs that require special claims processing
35%
Drugs that require prior authorization or step therapy
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PharmaVoice (PharmaVoice). (February 1, 2014). Share of indications which define a specialty drug as of 2011* [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/
PharmaVoice (PharmaVoice). "Share of indications which define a specialty drug as of 2011*." Chart. February 1, 2014. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/
PharmaVoice (PharmaVoice). (2014). Share of indications which define a specialty drug as of 2011*. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/
PharmaVoice (PharmaVoice). "Share of Indications Which Define a Specialty Drug as of 2011*." Statista, Statista Inc., 1 Feb 2014, https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/
PharmaVoice (PharmaVoice), Share of indications which define a specialty drug as of 2011* Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/ (last visited November 10, 2024)
Share of indications which define a specialty drug as of 2011* [Graph], PharmaVoice (PharmaVoice), February 1, 2014. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/380889/defining-specialty-drugs-among-pbms-and-pharmacy-executives/
